Biologically active ADAMTS13 is expressed in renal tubular epithelial cells

Minola Manea1, Ramesh Tati, Jessica Karlsson

  • 1Department of Pediatrics, Clinical Sciences Lund, Lund University, 22185 Lund, Sweden.

Insights

Human renal tubular epithelial cells synthesize active ADAMTS13, an enzyme crucial for regulating hemostasis. This protease is found in kidney tubules and urine, suggesting a local role in hemostasis within the renal microenvironment.

Area of Science:

  • Nephrology
  • Hematology
  • Molecular Biology

Background:

  • ADAMTS13 mRNA, encoding the von Willebrand factor-cleaving protease, is present in various tissues, including the kidney.
  • Previous studies have indicated the presence of ADAMTS13 in the kidney, but its specific localization and bioactivity within renal tubules were not fully characterized.

Purpose of the Study:

  • To investigate the expression and biological activity of ADAMTS13 within human renal tubular epithelial cells.
  • To determine the presence and localization of ADAMTS13 in normal and diseased renal tissues and urine.

Main Methods:

  • Real-time PCR was used to detect ADAMTS13 mRNA in cultured human renal tubular epithelial cells (HRTEC) and A498 cells.
  • Immunofluorescence and immunoblotting were employed to detect ADAMTS13 protein expression and secretion.
  • Immunohistochemistry was performed on renal tissue to localize ADAMTS13 in situ.
  • Proteolytic activity was assessed using the FRETS–VWF73 substrate.
  • Urine samples from patients with tubulopathy and healthy individuals were analyzed for ADAMTS13 presence.

Main Results:

  • ADAMTS13 mRNA and protein were detected in HRTEC and A498 cells.
  • The protein was found to be secreted and proteolytically active, cleaving the VWF substrate.
  • Immunohistochemistry confirmed ADAMTS13 presence in both proximal and distal renal tubules of normal and diseased kidneys.
  • ADAMTS13 was detected in the urine of patients with tubulopathy but not in normal urine.
  • The molecular size of urinary ADAMTS13 suggests renal tubular origin.

Conclusions:

  • Human renal tubular epithelial cells synthesize biologically active ADAMTS13.
  • ADAMTS13 is present and active within the renal tubules.
  • The presence of ADAMTS13 in urine of tubulopathy patients indicates its release from tubules.
  • Synthesized ADAMTS13 may regulate local hemostasis in the renal microenvironment.

Related Concept Videos

Renal Drug Excretion: Tubular Secretion01:28

Renal Drug Excretion: Tubular Secretion

Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
Physiology of the Genitourinary System II: Tubular Reabsorption and Secretion01:22

Physiology of the Genitourinary System II: Tubular Reabsorption and Secretion

The kidneys maintain homeostasis through filtration, reabsorption, and secretion. Tubular reabsorption and secretion are crucial in forming urine and regulating electrolytes, water balance, and waste elimination.Tubular Reabsorption and Secretion ProcessesTubular reabsorption is the process that reclaims essential substances such as electrolytes, glucose, amino acids, and water from the glomerular filtrate back into the bloodstream. This is achieved through passive and active transport...
Drug Elimination by Renal Route: Tubular Secretion01:15

Drug Elimination by Renal Route: Tubular Secretion

Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
Tubular Reabsorption and Secretion01:28

Tubular Reabsorption and Secretion

Tubular secretion and reabsorption are two critical processes in the nephron tubule of the kidneys. When the fluid filtered from the glomerulus enters the proximal convoluted tubule, it is referred to as filtrate, and its composition changes due to tubular reabsorption and secretion.
Tubular reabsorption is a selective process that starts when the filtrate enters the proximal tubules. It involves substances traveling through the transcellular route (through the tubule cell and peritubular...
Renal Tubule and Collecting Duct01:24

Renal Tubule and Collecting Duct

The renal tubule is divided into three parts: the proximal convoluted tubule (PCT), the Loop of Henle (LOH), and the distal convoluted tubule (DCT).
Proximal Convoluted Tubule (PCT):
The PCT is the initial segment of the renal tubule, extending from the Bowman's capsule that encloses the glomerulus. Its convoluted structure and microvilli-lined cells increase the surface area for reabsorption. The PCT reabsorbs glucose, amino acids, sodium, and water from the filtrate, ensuring essential...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...